Home › IGA Glomerulonephritis › Ohio
IGA Glomerulonephritis clinical trials in Ohio
5 studies for IGA Glomerulonephritis are looking for participants at sites in Ohio.
Cities in Ohio
Pediatric Longitudinal Glomerular Disease: a PNRC Multi-Institutional Cohort Study
- Cincinnati Children's Hospital Medical Center, Cincinnati
RecruitingObservational study
Up to age 18 · All sexes · Updated Nov 12, 2026 · NCT07931170Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
- Cincinnati Childrens Hospital MC, Cincinnati
RecruitingPhase 3
Ages 2 to 18 · All sexes · Updated Nov 6, 2026 · NCT07498335Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
- ADARx Clinical Site, Columbus
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 20, 2026 · NCT06989359Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN
- University Hospitals Cleveland Medical Center, Cleveland
- OSU Wexner Medical Center, Columbus
RecruitingPhase 2
Ages 18 to 99 · All sexes · Updated Jul 29, 2026 · NCT06797518Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Nationwide Children's Hospital, Columbus
RecruitingPhase 2
Ages 1 to 17 · All sexes · Updated May 12, 2026 · NCT05003986From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.